Interview with new CEO of Toronto cancer startup RNA Diagnostics - Jeremy Bridge-Cook
Rna Diagnostics News - April 2016
Q. You've worked in some very senior roles in the US In Vitro Diagnostics industry. Why did you decide to join Rna Diagnostics, a small Canadian startup? A. Rna Diagnostics provides an opportunity to commercialize a game-changing technology that promises to radically improve the treatment of cancer patients.
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.